Acknowledgement
This work was supported by Joint Fund Project of Zhejiang Provincial Natural Science Foundation and Pharmaceutical Association [Grant Number: LYY19H310004] and Zhejiang Medical and Health Science and Technology Plan Project [Grant Number: 2018KY183].
References
- Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. 2018. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: Cancer J. Clin. 68: 394-424. https://doi.org/10.3322/caac.21492
- Osarogiagbon RU, Veronesi G, Fang W, Ekman S, Suda K, Aerts JG, et al. 2019. Early-stage NSCLC: advances in thoracic oncology 2018. J. Thorac. Oncol. 14: 968-978. https://doi.org/10.1016/j.jtho.2019.02.029
- Gupta GP, Massague J. 2006. Cancer metastasis: building a framework. Cell 127: 679-695. https://doi.org/10.1016/j.cell.2006.11.001
- Yang P, Allen MS, Aubry MC, Wampfler JA, Marks RS, Edell ES, et al. 2005. Clinical features of 5,628 primary lung cancer patients: experience at Mayo Clinic from 1997 to 2003. Chest 128: 452-462. https://doi.org/10.1378/chest.128.1.452
- Sanger HL, Klotz G, Riesner D, Gross HJ, Kleinschmidt AK. 1976. Viroids are single-stranded covalently closed circular RNA molecules existing as highly base-paired rod-like structures. Proc. Natl. Acad. Sci. USA 73: 3852-3856. https://doi.org/10.1073/pnas.73.11.3852
- Cocquerelle C, Mascrez B, Hetuin D, Bailleul B. 1993. Mis-splicing yields circular RNA molecules. FASEB J. 7: 155-160. https://doi.org/10.1096/fasebj.7.1.7678559
- Xu T, Wu J, Han P, Zhao Z, Song X. 2017. Circular RNA expression profiles and features in human tissues: a study using RNA-seq data. BMC Genomics 18: 680. https://doi.org/10.1186/s12864-017-4029-3
- Zhang ZY, Gao XH, Ma MY, Zhao CL, Zhang YL, Guo SS. 2020. CircRNA_101237 promotes NSCLC progression via the miRNA-490-3p/MAPK1 axis. Sci. Rep. 10: 9024. https://doi.org/10.1038/s41598-020-65920-2
- Chen RX, Liu HL, Yang LL, Kang FH, Xin LP, Huang LR, et al. 2019. Circular RNA circRNA_0000285 promotes cervical cancer development by regulating FUS. Eur. Rev. Med. Pharmacol. Sci. 23: 8771-8778.
- Han J, Zhao G, Ma X, Dong Q, Zhang H, Wang Y, et al. 2018. CircRNA circ-BANP-mediated miR-503/LARP1 signaling contributes to lung cancer progression. Biochem. Biophys. Res. Commun. 503: 2429-2435. https://doi.org/10.1016/j.bbrc.2018.06.172
- Wu J, Vogel T, Gao X, Lin B, Kulwin C, Chen J. 2018. Neuroprotective effect of dexmedetomidine in a murine model of traumatic brain injury. Sci Rep. 8: 4935. https://doi.org/10.1038/s41598-018-23003-3
- Han F, Zhong C, Li W, Wang R, Zhang C, Yang X, et al. 2020. hsa_circ_0001947 suppresses acute myeloid leukemia progression via targeting hsa-miR-329-5p/CREBRF axis. Epigenomics 12: 935-953. https://doi.org/10.2217/epi-2019-0352
- Cai X, Lin L, Zhang Q, Wu W, Su A. 2020. Bioinformatics analysis of the circRNA-miRNA-mRNA network for non-small cell lung cancer. J. Int Med. Res. 48: 300060520929167.
- Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. 2013. Natural RNA circles function as efficient microRNA sponges. Nature 495: 384-388. https://doi.org/10.1038/nature11993
- Kozomara A, Griffiths-Jones S. 2011. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39: D152-157. https://doi.org/10.1093/nar/gkq1027
- Wang T, Wang X, Du Q, Wu N, Liu X, Chen Y, et al. 2019. The circRNA circP4HB promotes NSCLC aggressiveness and metastasis by sponging miR-133a-5p. Biochem. Biophys. Res. Commun. 513: 904-911. https://doi.org/10.1016/j.bbrc.2019.04.108
- Wei S, Zheng Y, Jiang Y, Li X, Geng J, Shen Y, et al. 2019. The circRNA circPTPRA suppresses epithelial-mesenchymal transitioning and metastasis of NSCLC cells by sponging miR-96-5p. EBioMedicine 44: 182-193. https://doi.org/10.1016/j.ebiom.2019.05.032
- Li C, Fei K, Tian F, Gao C, Yang S. 2019. Adipose-derived mesenchymal stem cells attenuate ischemic brain injuries in rats by modulating miR-21-3p/MAT2B signaling transduction. Croat. Med. J. 60: 439-448. https://doi.org/10.3325/cmj.2019.60.439
- Gu H, Chen J, Song Y, Shao H. 2018. Gastric adenocarcinoma predictive long intergenic non-coding RNA promotes tumor occurrence and progression in non-small cell lung cancer via regulation of the miR-661/eEF2K signaling pathway. Cell. Physiol. Biochem. 51: 2136-2147. https://doi.org/10.1159/000495831
- Yu W, Sun Z, Yang L, Han Y, Yue L, Deng L, et al. 2019. lncRNA PTAR promotes NSCLC cell proliferation, migration and invasion by sponging microRNA-101. Mol. Md. Rep. 20: 4168-4174.
- Bu X, Chen Z, Zhang A, Zhang X, Yuan H, Zhang Y, et al. 2021. Circular RNA circAFF2 accelerates gastric cancer development by activating miR-6894-5p and regulating ANTXR 1 expression. Clin. Res. Hepatol. Gastroenterol. 45: 101671. https://doi.org/10.1016/j.clinre.2021.101671
- Chen X, Chen RX, Wei WS, Li YH, Feng ZH, Tan L, et al. 2018. PRMT5 circular RNA promotes metastasis of urothelial carcinoma of the bladder through sponging miR-30c to induce epithelial-mesenchymal transition. Clin. Cancer Res. 24: 6319-6330. https://doi.org/10.1158/1078-0432.CCR-18-1270
- Zhu T, Yuan J, Wang Y, Gong C, Xie Y, Li H. 2015. MiR-661 contributed to cell proliferation of human ovarian cancer cells by repressing INPP5J expression. Biomed. Pharmacother. 75: 123-128. https://doi.org/10.1016/j.biopha.2015.07.023
- Li Z, Liu YH, Diao HY, Ma J, Yao YL. 2015. MiR-661 inhibits glioma cell proliferation, migration and invasion by targeting hTERT. Biochem. Biophys. Res. Commun. 468: 870-876. https://doi.org/10.1016/j.bbrc.2015.11.046
- Wang ZM, Wan XH, Sang GY, Zhao JD, Zhu QY, Wang DM. 2017. miR-15a-5p suppresses endometrial cancer cell growth via Wnt/beta-catenin signaling pathway by inhibiting WNT3A. Eur. Rev. Med. Pharmacol. Sci. 21: 4810-4818.
- Liu F, Cai Y, Rong X, Chen J, Zheng D, Chen L, et al. 2017. MiR-661 promotes tumor invasion and metastasis by directly inhibiting RB1 in non small cell lung cancer. Mol. Cancer 16: 122. https://doi.org/10.1186/s12943-017-0698-4
- Chen G, Yu H, Satherley L, Zabkiewicz C, Resaul J, Zhao H, et al. 2017. The downstream of tyrosine kinase 7 is reduced in lung cancer and is associated with poor survival of patients with lung cancer. Oncol. Rep. 37: 2695-2701. https://doi.org/10.3892/or.2017.5538
- Berger AH, Niki M, Morotti A, Taylor BS, Socci ND, Viale A, et al. 2010. Identification of DOK genes as lung tumor suppressors. Nat. Genet. 42: 216-223. https://doi.org/10.1038/ng.527
- Heyn H, Carmona FJ, Gomez A, Ferreira HJ, Bell JT, Sayols S, et al. 2013. DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarker. Carcinogenesis 34: 102-108. https://doi.org/10.1093/carcin/bgs321
- Niki M, Di Cristofano A, Zhao M, Honda H, Hirai H, Van Aelst L, et al. 2004. Role of Dok-1 and Dok-2 in leukemia suppression. J. Exp. Med. 200: 1689-1695. https://doi.org/10.1084/jem.20041306